AB1591-HPR BRAVE NEW WORLD: DO PATIENTS WITH RHEUMATIC DISEASES WANT A CHOICE, AND HAVE A PREFERENCE, IN HOW THEY MANAGE THEIR FATIGUE? (2024)

AB1591-HPR BRAVE NEW WORLD: DO PATIENTS WITH RHEUMATIC DISEASES WANT A CHOICE, AND HAVE A PREFERENCE, IN HOW THEY MANAGE THEIR FATIGUE? (1)

  • Subscribe
  • Log In More

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

  • Basket
  • Search More

    Advanced search

  • Latest content
  • Current issue
  • Archive
  • Authors
  • About
  • Podcasts

Advanced search

  • CloseMore

    Main menu

    • Latest content
    • Current issue
    • Archive
    • Authors
    • About
    • Podcasts
  • Subscribe
  • Log in More

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

  • BMJ Journals

You are here

  • Home
  • Archive
  • Volume 83,Issue Suppl 1
  • AB1591-HPR BRAVE NEW WORLD: DO PATIENTS WITH RHEUMATIC DISEASES WANT A CHOICE, AND HAVE A PREFERENCE, IN HOW THEY MANAGE THEIR FATIGUE?

Email alerts

Article Text

Article menu

  • Article Text
  • Article info
  • Citation Tools
  • Share
  • Rapid Responses
  • Article metrics
  • Alerts

PDF

Health Professionals in Rheumatology Abstracts

Publication Only

HPR Patients perspectives

AB1591-HPR BRAVE NEW WORLD: DO PATIENTS WITH RHEUMATIC DISEASES WANT A CHOICE, AND HAVE A PREFERENCE, IN HOW THEY MANAGE THEIR FATIGUE?

  1. J. Dobson1,
  2. D. Dockrell1,
  3. K. Berg1,
  4. H. Harris2
  1. 1University of Edinburgh, Centre for Genomic and Experimental Medicine, Edinburgh, United Kingdom
  2. 2NHS Lothian, Rheumatology, Edinburgh, United Kingdom

Abstract

Background: The probability of developing an autoimmune inflammatory rheumatic disease (RMD) in one’s lifetime is 1 in 12 for women and 1 in 20 for men. [1]. Fatigue is reported as one of the most common symptoms of RMDs but remains poorly understood or treated. Studies have shown that fatigue is present in 1 in every 2 patients with RMDs [2]. Up to 70% of patients experience a negative effect on quality of life as result of their fatigue [3]. Fatigue management is not standardised in the United Kingdom and remains inadequately addressed in a real-world setting for RMD patients. [4]. The EULAR 2023 overarching principles and recommendations for fatigue management in RMDs and MSK diseases advocates for, amongst others, shared decision making on treatment between patient and HCP and access to tailored physical activity interventions, and structured psychoeducational interventions [5,6].

Objectives: The primary objective was to establish whether personal choice of fatigue management approaches was important to RMD patients with fatigue. The secondary objective was to determine which would be their preferred fatigue management approach when given that choice.

Methods: A cross sectional survey using the JISC online survey tool was distributed to NHS Lothian RMD patients in Autumn 2023. All respondents had previously been referred to the fatigue management team between January 2020 and September 2023.

Results: Of those who responded (n=50), 83% indicated that they would like the opportunity to choose their fatigue management plan. Respondents were then asked to choose their top preferences, Table 1.

Table 1. Fatigue management options

  • Download figure
  • Open in new tab
  • Download powerpoint

The most popular fatigue management option was a live online group fatigue programme, with 68% of respondents choosing this as their first or second option. This was followed by occupational therapy, which was a first or second option for 44% of the group.

Conclusion: The majority of RMD patients would prefer to have a choice in their fatigue management approach, there is limited patient interest in physiotherapy as an option. Despite increasing recognition of the impact of fatigue on RMD patients [5] the only option provided by the majority of NHS hospitals are booklets, which were found to be of minimal interest in this study population. When clinicians and stakeholders consider which fatigue management options to fund, this study indicates increased weight should be given to live online groups and occupational therapy.

REFERENCES: [1] Crowson, C.S., Matteson, E.L., Myasoedova, E., Michet, C.J., Ernste, F.C., Warrington, K.J., Davis, J.M., Hunder, G.G., Therneau, T.M. and Gabriel, S.E. (2011). The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis & Rheumatism, 63(3), pp.633–639. doi:https://doi.org/10.1002/art.30155.

[2] Katie L Druce, Neil Basu, Predictors of fatigue in rheumatoid arthritis, Rheumatology, Volume 58, Issue Supplement_5, November 2019, Pages v29–v34, https://doi.org/10.1093/rheumatology/kez346.

[3] Seifert O, Baerwald C. Impact of fatigue on rheumatic diseases,Best Practice & Research Clinical Rheumatology,Volume 33, ISjSue 3,2019,101435,ISJSN 1521-6942,https://doi.org/10.1016/j.berh.2019.101435.

[4] Pope JE. Management of Fatigue in Rheumatoid Arthritis. SJS Open 2020;6: e001084. doi:10.1136/ SjSopen-2019-001084.

[5] Dures E, Farisoğullari B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Epub ahead of print. PMID: 38050029.

[6] Clark NM, Janz NK, Dodge JA, Mosca L, Lin X, Long Q, Little RJ, Wheeler JR, Keteyian S, Liang J. The effect of patient choice of intervention on health outcomes. Contemp Clin Trials. 2008 Sep;29(5):679-86. doi: 10.1016/j.cct.2008.04.002. Epub 2008 Apr 20. PMID: 18515187; PMCID: PMC2577598.

Acknowledgements: NIL.

Disclosure of Interests: Joanne Dobson: None declared, Dervil Dockrell: None declared, Kathryn Berg: None declared, Helen Harris Galapagos.

  • Non-pharmacological interventions
  • Quality of life
  • Health services research
  • Patient information and education

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    • Non-pharmacological interventions
    • Quality of life
    • Health services research
    • Patient information and education

    Read the full text or download the PDF:

    Subscribe

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

    Read the full text or download the PDF:

    Subscribe

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

    AB1591-HPR BRAVE NEW WORLD: DO PATIENTS WITH RHEUMATIC DISEASES WANT A CHOICE, AND HAVE A PREFERENCE, IN HOW THEY MANAGE THEIR FATIGUE? (2024)

    References

    Top Articles
    Latest Posts
    Article information

    Author: Terrell Hackett

    Last Updated:

    Views: 5594

    Rating: 4.1 / 5 (72 voted)

    Reviews: 95% of readers found this page helpful

    Author information

    Name: Terrell Hackett

    Birthday: 1992-03-17

    Address: Suite 453 459 Gibson Squares, East Adriane, AK 71925-5692

    Phone: +21811810803470

    Job: Chief Representative

    Hobby: Board games, Rock climbing, Ghost hunting, Origami, Kabaddi, Mushroom hunting, Gaming

    Introduction: My name is Terrell Hackett, I am a gleaming, brainy, courageous, helpful, healthy, cooperative, graceful person who loves writing and wants to share my knowledge and understanding with you.